Key facts
- This page summarizes Eric Weisblum's Form 4 filing for Silo Pharma, Inc. (SILO).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 16 Dec 2025, 18:34.
Eric Weisblum - 15 Dec 2025 Form 4 Insider Report for Silo Pharma, Inc. (SILO)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- SILO
- Reported as of
- 15 Dec 2025
- Net transaction value
- +$2,075
- SEC form
- 4
- Accepted by SEC
- 16 Dec 2025, 18:34:59 UTC
- Prior SEC filing
- 21 Nov 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Eric Weisblum
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Eric Weisblum filed Form 4 for Silo Pharma, Inc. (SILO) on 16 Dec 2025.
Change
- Previous filing in this sequence was filed on 21 Nov 2025.
- Current net transaction value: +$2,075.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001569077
Primary reporting owner
Weisblum Eric
- Relationship
- Chief Executive Officer, Director
- Address
- C/O SILO PHARMA, INC., 677 N. WASHINGTON BOULEVARD, SARASOTA
- Signature
- /s/ Eric Weisblum
- Signature date
- 16 Dec 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
SILO
transaction
Common Stock
Purchase
- Transaction value
- $1,025
- Shares
- +2,500
- Change %
- +1.2%
- Price
- $0.4100
- Shares after
- 214,432
- Date
- 15 Dec 2025
- Ownership
- Direct
SILO
transaction
Common Stock
Purchase
- Transaction value
- $1,050
- Shares
- +2,500
- Change %
- +1.2%
- Price
- $0.4200
- Shares after
- 216,932
- Date
- 15 Dec 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.